{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:06:59Z","timestamp":1789567619786,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1159261"],"award-info":[{"award-number":["1159261"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.placenta.2026.05.003","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:26:18Z","timestamp":1778282778000},"page":"108-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Brain and C-type natriuretic peptide are expressed by the human placenta and are not altered with preeclampsia, fetal growth restriction, or placental hypoxia"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-784X","authenticated-orcid":false,"given":"Bianca R.","family":"Fato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"de Alwis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Beard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Kodila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia P.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu'uhevaha J.","family":"Kaitu'u-Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J.","family":"Bubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8446-2250","authenticated-orcid":false,"given":"Natalie J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"14","key":"10.1016\/j.placenta.2026.05.003_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147569","article-title":"A narrative review on the pathophysiology of preeclampsia","volume":"25","author":"Torres-Torres","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/reprod\/xaag011","article-title":"Exploring placental dysfunction: models of extracellular vesicle action in preeclampsia","volume":"171","author":"Fato","year":"2026","journal-title":"Reproduction"},{"issue":"8","key":"10.1016\/j.placenta.2026.05.003_bib5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.molmed.2021.05.003","article-title":"Pre-eclampsia: challenges for nanomedicine development in pregnancy","volume":"27","author":"de Alwis","year":"2021","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib6","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5499","article-title":"Importance of STAT3 signaling in preeclampsia","volume":"55","author":"Marzioni","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.placenta.2026.05.003_bib7","series-title":"Stillbirths and Neonatal Deaths in Australia 2017 and 2018","year":"2021"},{"issue":"3","key":"10.1016\/j.placenta.2026.05.003_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \"Great Obstetrical Syndromes\" are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2026.05.003_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/micc.12290","article-title":"Characterization of relaxant responses to natriuretic peptides in the human microcirculation in vitro and in vivo","volume":"23","author":"Edvinsson","year":"2016","journal-title":"Microcirculation"},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3317\/jraas.2006.014","article-title":"CNP, but not ANP or BNP, relax human isolated subcutaneous resistance arteries by an action involving cyclic GMP and BKCa channels","volume":"7","author":"Garcha","year":"2006","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"3","key":"10.1016\/j.placenta.2026.05.003_bib11","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/01.CIR.90.3.1210","article-title":"Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure","volume":"90","author":"Nakamura","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.placenta.2026.05.003_bib12","first-page":"S144","article-title":"C-type natriuretic peptide in chronic renal failure and its action in humans","volume":"55","author":"Igaki","year":"1996","journal-title":"Kidney Int. Suppl."},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.37.4.1179","article-title":"C-Type natriuretic peptide\u2013induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels","volume":"37","author":"Honing","year":"2001","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.placenta.2026.05.003_bib14","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1172\/JCI74281","article-title":"Endothelial C-type natriuretic peptide maintains vascular homeostasis","volume":"124","author":"Moyes","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.116.08219","article-title":"Endothelium-derived C-Type natriuretic peptide contributes to blood pressure regulation by maintaining endothelial integrity","volume":"69","author":"Nakao","year":"2017","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.placenta.2026.05.003_bib16","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3390\/ijms20092281","article-title":"C-Type natriuretic peptide: a multifaceted paracrine regulator in the heart and vasculature","volume":"20","author":"Moyes","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.placenta.2026.05.003_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/01.ATV.21.6.930","article-title":"C-Type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization","volume":"21","author":"Doi","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/bbrc.1993.1616","article-title":"C-Type natriuretic peptide inhibits intimal thickening after vascular injury","volume":"193","author":"Furuya","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.placenta.2026.05.003_bib19","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.118.036344","article-title":"Endothelial C-Type natriuretic peptide is a critical regulator of angiogenesis and vascular remodeling","volume":"139","author":"Bubb","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jcem-69-4-729","article-title":"Expression of the atrial natriuretic peptide gene in human fetal heart","volume":"69","author":"Gardner","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2015.06.029","article-title":"Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)","volume":"569","author":"Song","year":"2015","journal-title":"Gene"},{"issue":"6159","key":"10.1016\/j.placenta.2026.05.003_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","article-title":"A new natriuretic peptide in porcine brain","volume":"332","author":"Sudoh","year":"1988","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib23","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide","volume":"87","author":"Mukoyama","year":"1991","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.placenta.2026.05.003_bib24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199009133231114","article-title":"Increased human brain natriuretic peptide in congestive heart failure","volume":"323","author":"Mukoyama","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.placenta.2026.05.003_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/01.HYP.27.3.715","article-title":"Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes","volume":"27","author":"LaPointe","year":"1996","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.placenta.2026.05.003_bib26","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1210\/endo.133.6.8243333","article-title":"Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells\u2014evidence for CNP as a novel autocrine\/paracrine regulator from endothelial cells","volume":"133","author":"Suga","year":"1993","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib27","doi-asserted-by":"crossref","first-page":"H1318","DOI":"10.1152\/ajpheart.1992.263.4.H1318","article-title":"Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma","volume":"263","author":"Stingo","year":"1992","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-291X(90)92401-K","article-title":"C-Type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain","volume":"168","author":"Sudoh","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.placenta.2026.05.003_bib29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.peptides.2011.06.014","article-title":"Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes","volume":"32","author":"Del Ry","year":"2011","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.placenta.2026.05.003_bib30","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1210\/en.2003-0128","article-title":"Gene expression, secretion, and autocrine action of C-Type natriuretic peptide in cultured adult rat cardiac fibroblasts","volume":"144","author":"Horio","year":"2003","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and Cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Potter","year":"2006","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib33","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1016\/S0021-9258(18)53749-2","article-title":"Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides","volume":"268","author":"Chrisman","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.placenta.2026.05.003_bib34","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/00004872-199715110-00007","article-title":"Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats","volume":"15","author":"Nagase","year":"1997","journal-title":"J. Hypertens."},{"issue":"7","key":"10.1016\/j.placenta.2026.05.003_bib35","first-page":"3454","article-title":"Differential regional expression of three natriuretic peptide receptor genes within primate tissues","volume":"11","author":"Wilcox","year":"1991","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/en.2002-220702","article-title":"Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B","volume":"144","author":"Abbey","year":"2003","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.placenta.2026.05.003_bib37","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.3390\/ijms24076182","article-title":"Investigating the effects of atrial natriuretic peptide on the maternal endothelium to determine potential implications for Preeclampsia","volume":"24","author":"Binder","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.placenta.2026.05.003_bib38","doi-asserted-by":"crossref","first-page":"12190","DOI":"10.21037\/apm-21-2981","article-title":"Prediction of adverse maternal and perinatal outcomes in preeclampsia based on B-type natriuretic peptide: a retrospective study","volume":"10","author":"Hong","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ajog.2004.12.006","article-title":"Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women","volume":"193","author":"Resnik","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2026.05.003_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1447-0756.1999.tb01185.x","article-title":"Brain natriuretic peptide (BNP) and cyclic guanosine monophosphate (cGMP) levels in normal pregnancy and preeclampsia","volume":"25","author":"Okuno","year":"1999","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/10641959909023077","article-title":"Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy","volume":"18","author":"Kaaja","year":"1999","journal-title":"Hypertens. Pregnancy"},{"issue":"12","key":"10.1016\/j.placenta.2026.05.003_bib42","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.clinbiochem.2011.05.026","article-title":"Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity","volume":"44","author":"Sandrim","year":"2011","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1515\/cclm-2013-0307","article-title":"Increased B-type natriuretic peptide levels in early-onset versus late-onset preeclampsia","volume":"52","author":"Szab\u00f3","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib44","first-page":"73","article-title":"Brain natriuretic peptide and atrial natriuretic peptide levels in normal pregnancy and preeclampsia","volume":"38","author":"Furuhashi","year":"1994","journal-title":"Gynecol. Obstet. Invest."},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/echo.13817","article-title":"Left ventricular function of patients with pregnancy-induced hypertension evaluated using velocity vector imaging echocardiography and N-terminal pro-brain natriuretic peptide","volume":"35","author":"Yu","year":"2018","journal-title":"Echocardiography"},{"key":"10.1016\/j.placenta.2026.05.003_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.preghy.2021.12.014","article-title":"Association between brain natriuretic peptide and cardiac dysfunction in hypertensive pregnancy disorders","volume":"27","author":"Oliveros-Ruiz","year":"2022","journal-title":"Pregnancy Hypertens."},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/uog.17495","article-title":"Maternal left ventricular hypertrophy and diastolic dysfunction and brain natriuretic peptide concentration in early- and late-onset pre-eclampsia","volume":"51","author":"Borges","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.05.003_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clinbiochem.2019.03.005","article-title":"Circulating NT-proBNP but not soluble corin levels were associated with preeclampsia in pregnancy-associated hypertension","volume":"67","author":"Kumari","year":"2019","journal-title":"Clin. Biochem."},{"issue":"9","key":"10.1016\/j.placenta.2026.05.003_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162957","article-title":"Prenatal clinical assessment of NT-proBNP as a diagnostic tool for Preeclampsia, gestational hypertension and gestational diabetes mellitus","volume":"11","author":"Sadlecki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2026.05.003_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mehy.2018.09.034","article-title":"B-type natriuretic peptides in pregnant women with normal heart or cardiac disorders","volume":"121","author":"Balaceanu","year":"2018","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.placenta.2026.05.003_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/IBPC.S360584","article-title":"Serum levels of NT-Pro BNP in patients with Preeclampsia","volume":"15","author":"Nguyen","year":"2022","journal-title":"Integrated Blood Pres. Control"},{"issue":"9","key":"10.1016\/j.placenta.2026.05.003_bib52","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/ajh\/hpu033","article-title":"Placental expression of proBNP\/NT-proBNP and plasma levels of NT-proBNP in Early- and late-onset preeclampsia","volume":"27","author":"Junus","year":"2014","journal-title":"Am. J. Hypertens."},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/jpm.2011.065","article-title":"Natriuretic peptide levels in intrauterine growth-restricted fetuses with absent and reversed end-diastolic flow of the umbilical artery in relation to ductus venosus flow velocities","volume":"39","author":"Bahlmann","year":"2011","journal-title":"J. Perinat. Med."},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib54","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/15513815.2021.1955057","article-title":"Maternal serum and umbilical cord Brain natriuretic peptide levels in fetuses with intrauterine growth restriction","volume":"41","author":"Ero\u011flu","year":"2022","journal-title":"Fetal Pediatr. Pathol."},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/jpm.2011.065","article-title":"Natriuretic peptide levels in intrauterine growth-restricted fetuses with absent and reversed end-diastolic flow of the umbilical artery in relation to ductus venosus flow velocities","volume":"39","author":"Bahlmann","year":"2011","journal-title":"J. Perinat. Med."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejogrb.2013.09.001","article-title":"Cord blood B-type natriuretic peptide levels in placental insufficiency: correlation with fetal Doppler and pH at birth","volume":"171","author":"Costa","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/pr.2014.22","article-title":"Neonatal cardiac dysfunction in intrauterine growth restriction","volume":"75","author":"Fouzas","year":"2014","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib58","first-page":"199","article-title":"C-type natriuretic peptide levels in women with gestational hypertension and preeclampsia","volume":"93","author":"Stepan","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.05.003_bib59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.preghy.2018.01.007","article-title":"Dynamics of serum C-type natriuretic peptide as predictor for preeclampsia","volume":"14","author":"Kuessel","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.placenta.2026.05.003_bib60","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.preghy.2018.01.007","article-title":"Dynamics of serum C-type natriuretic peptide as predictor for preeclampsia","volume":"14","author":"Kuessel","year":"2018","journal-title":"Pregnancy Hypertens."},{"issue":"9","key":"10.1016\/j.placenta.2026.05.003_bib61","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/1471-0528.13397","article-title":"Effects of pre-eclampsia and fetal growth restriction on C-type natriuretic peptide","volume":"122","author":"Espiner","year":"2015","journal-title":"British Journal of Obsterics and Gynaecology"},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib62","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/jc.2013-3758","article-title":"C-Type natriuretic peptide in complicated pregnancy: increased secretion precedes adverse events","volume":"99","author":"Reid","year":"2014","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"9","key":"10.1016\/j.placenta.2026.05.003_bib63","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/HYPERTENSIONAHA.124.22820","article-title":"Exploring the therapeutic potential of C-Type natriuretic peptide for Preeclampsia","volume":"81","author":"Fato","year":"2024","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib64","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in Pregnancy: executive Summary","volume":"122","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib65","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5694\/mja11.11331","article-title":"Australian national birthweight percentiles by sex and gestational age, 1998-2007","volume":"197","author":"Dobbins","year":"2012","journal-title":"Med. J. Aust."},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.preghy.2014.09.003","article-title":"Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin","volume":"4","author":"Kaitu\u2019u-Lino","year":"2014","journal-title":"Pregnancy Hypertens.: An International Journal of Women's Cardiovascular Health"},{"key":"10.1016\/j.placenta.2026.05.003_bib67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.placenta.2023.07.013","article-title":"Cell surface associated protein mucin 15 (MUC15) is elevated in preeclampsia","volume":"140","author":"Nguyen","year":"2023","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12958-023-01116-3","article-title":"Paternal Expressed Gene 10 (PEG10) is decreased in early-onset preeclampsia","volume":"21","author":"Baird","year":"2023","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000048004","article-title":"Expression of C-type natriuretic peptide in human placenta and myometrium in normal pregnancies and pregnancies complicated by intrauterine growth retardation. Preliminary results","volume":"17","author":"Stepan","year":"2002","journal-title":"Fetal Diagn. Ther."},{"issue":"8","key":"10.1016\/j.placenta.2026.05.003_bib70","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.070371497","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide","volume":"97","author":"Tamura","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.placenta.2026.05.003_bib71","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1210\/endo.137.3.8603590","article-title":"The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta","volume":"137","author":"Cameron","year":"1996","journal-title":"Endocrinology"},{"issue":"9741","key":"10.1016\/j.placenta.2026.05.003_bib72","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"issue":"2\u20133","key":"10.1016\/j.placenta.2026.05.003_bib73","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.placenta.2003.10.010","article-title":"Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies","volume":"25","author":"Mayhew","year":"2004","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.placenta.2026.05.003_bib74","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","article-title":"Placental origins of Preeclampsia","volume":"51","author":"Huppertz","year":"2008","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0002-9378(00)41620-0","article-title":"Preeclampsia: evidence for impaired shear stress-mediated nitric oxide release in uterine circulation","volume":"183","author":"Kublickiene","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2 Pt 1","key":"10.1016\/j.placenta.2026.05.003_bib76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.HYP.30.2.247","article-title":"Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia","volume":"30","author":"Cockell","year":"1997","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.placenta.2026.05.003_bib77","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/humrep\/dey225","article-title":"Trophoblast plugs: impact on utero-placental haemodynamics and spiral artery remodelling","volume":"33","author":"James","year":"2018","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.placenta.2026.05.003_bib78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10641955.2021.1921794","article-title":"Tumor necrosis factor alpha expression is increased in maternal microvascular endothelial cells in preeclampsia","volume":"40","author":"Lee","year":"2021","journal-title":"Hypertens. Pregnancy"},{"issue":"1","key":"10.1016\/j.placenta.2026.05.003_bib79","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-016-8596-x","article-title":"Tumor necrosis factor-alpha and pregnancy: focus on biologics. An updated and comprehensive review","volume":"53","author":"Alijotas-Reig","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib80","first-page":"412","article-title":"Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis","volume":"70","author":"Lau","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib81","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0029-7844(95)00259-T","article-title":"Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia","volume":"86","author":"Baker","year":"1995","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib82","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1067\/mob.2001.108342","article-title":"Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance","volume":"184","author":"Bosio","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2026.05.003_bib83","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.HYP.36.6.965","article-title":"Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy","volume":"36","author":"Hunter","year":"2000","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.placenta.2026.05.003_bib84","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1046\/j.1365-2362.1996.830605.x","article-title":"Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia","volume":"26","author":"Sharkey","year":"1996","journal-title":"Eur. J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.placenta.2026.05.003_bib85","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib86","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1471-0528.1997.tb11050.x","article-title":"Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia","volume":"104","author":"Lyall","year":"1997","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"10","key":"10.1016\/j.placenta.2026.05.003_bib87","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-0528.1999.tb08107.x","article-title":"Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia","volume":"106","author":"Reuvekamp","year":"1999","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"6","key":"10.1016\/j.placenta.2026.05.003_bib88","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1067\/mob.2000.108022","article-title":"Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia","volume":"183","author":"Livingston","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"15","key":"10.1016\/j.placenta.2026.05.003_bib89","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2217\/bmm-2019-0208","article-title":"The transforming growth factor \u03b2 superfamily as possible biomarkers of preeclampsia: a comprehensive review","volume":"13","author":"Adu-Gyamfi","year":"2019","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.placenta.2026.05.003_bib90","article-title":"Role of transforming growth Factor-\u03b21 in regulating fetal-maternal immune tolerance in normal and pathological pregnancy","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.placenta.2026.05.003_bib91","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.placenta.2026.05.003_bib92","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0014-5793(95)01027-C","article-title":"Shear stress induces expression of CNP gene in human endothelial cells","volume":"373","author":"Okahara","year":"1995","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"issue":"3","key":"10.1016\/j.placenta.2026.05.003_bib93","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.rvsc.2012.10.002","article-title":"Interleukin-1\u03b2, tumour necrosis factor-\u03b1 and lipopolysaccharide induce C-type natriuretic peptide from canine aortic endothelial cells","volume":"94","author":"Osterbur","year":"2013","journal-title":"Res. Vet. Sci."},{"issue":"3","key":"10.1016\/j.placenta.2026.05.003_bib94","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1172\/JCI115933","article-title":"Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of \"vascular natriuretic peptide system\"","volume":"90","author":"Suga","year":"1992","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.placenta.2026.05.003_bib95","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.HYP.27.3.811","article-title":"Vascular endothelial growth factor suppresses C-Type natriuretic peptide secretion","volume":"27","author":"Doi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.05.003_bib96","series-title":"Disclosure: Shashikanth Ambati Declares No Relevant Financial Relationships with Ineligible Companies.: Statpearls Publishing Copyright \u00a9 2025","article-title":"Placental Insufficiency. StatPearls. Treasure Island (FL) ineligible companies","author":"Wardinger","year":"2025"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014340042600161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014340042600161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:26:39Z","timestamp":1789565199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014340042600161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":96,"alternative-id":["S014340042600161X"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2026.05.003","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain and C-type natriuretic peptide are expressed by the human placenta and are not altered with preeclampsia, fetal growth restriction, or placental hypoxia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2026.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}